tradingkey.logo
tradingkey.logo
Search

Mereo BioPharma Reports Full Year 2024 Financial Results And Provides Corporate Highlights

ReutersMar 26, 2025 11:40 AM
facebooktwitterlinkedin

- Mereo Biopharma Group PLC MAH0y.F:

  • MEREO BIOPHARMA REPORTS FULL YEAR 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE HIGHLIGHTS

  • MEREO BIOPHARMA GROUP PLC - ORBIT PHASE 3 STUDY OF SETRUSUMAB PROGRESSING SECOND INTERIM ANALYSIS, EXPECTED MID-2025

Further company coverage: [MAH0y.F]

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

Tradingkey
KeyAI